HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Dive Selected Research

Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)

6/2018Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Dive Research Topics

Disease

3Multiple Sclerosis
05/2020 - 09/2017
2Malaria
08/2011 - 03/2001
1Relapsing-Remitting Multiple Sclerosis
06/2018
1Membranous Glomerulonephritis (Membranous Nephropathy)
06/2018
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2018
1Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
06/2018
1Pain (Aches)
05/2005

Drug/Important Bio-Agent (IBA)

1Alemtuzumab (Campath)FDA Link
06/2018
1Monoclonal AntibodiesIBA
06/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2017
1ferroquineIBA
08/2011
1ferrochloroquineIBA
03/2001
1Chloroquine (Aralen)FDA LinkGeneric
03/2001
1Antimalarials (Antimalarial Agents)IBA
03/2001

Therapy/Procedure

2Therapeutics
05/2020 - 05/2005